ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 174 filers reported holding ACCELERON PHARMA INC in Q1 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $129,000 | +4.9% | 1,350 | -1.5% | 0.01% | 0.0% |
| Q1 2020 | $123,000 | +68.5% | 1,370 | 0.0% | 0.01% | +133.3% |
| Q4 2019 | $73,000 | +35.2% | 1,370 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $54,000 | +54.3% | 1,370 | +63.1% | 0.00% | +100.0% |
| Q2 2019 | $35,000 | -10.3% | 840 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $39,000 | -74.7% | 840 | -76.3% | 0.00% | -80.0% |
| Q4 2018 | $154,000 | -23.8% | 3,540 | -40.4% | 0.01% | -16.7% |
| Q2 2016 | $202,000 | -77.0% | 5,940 | -74.3% | 0.01% | -79.3% |
| Q1 2015 | $879,000 | -9.4% | 23,090 | -7.2% | 0.03% | -14.7% |
| Q4 2014 | $970,000 | +17.1% | 24,890 | -9.2% | 0.03% | +9.7% |
| Q3 2014 | $828,000 | – | 27,400 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,103,937 | $53,563,000 | 5.39% |
| GREAT POINT PARTNERS LLC | 758,000 | $36,778,000 | 5.10% |
| Foresite Capital Management II, LLC | 244,756 | $11,876,000 | 4.18% |
| GREAT POINT PARTNERS LLC | 552,300 | $26,798,000 | 3.71% |
| Foresite Capital Management III, LLC | 278,753 | $13,525,000 | 2.91% |
| QVT Financial LP | 190,977 | $9,266,000 | 2.66% |
| Perceptive Advisors | 1,528,205 | $74,149,000 | 1.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,800 | $54,672,000 | 1.92% |
| SECTORAL ASSET MANAGEMENT INC | 306,626 | $14,877,000 | 1.66% |
| Parametrica Management Ltd | 5,645 | $274,000 | 1.30% |